Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

Journal of Clinical Oncology(2022)10.1200/jco.21.02419Source: DataRank Database

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative is a dataset published in Journal of Clinical Oncology (2022). On theSindex it has a DataRank of 4.6, placing it in the top 4.8% of the data-sharing corpus. It has been cited 111 times, with 100 citing works in its 1-hop citation network.

Top 5%percentile

4.6DataRank

Ranks in the top 5% for downstream scientific impact

Data paper Open Access111 citations · 100 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (74 grants)OA: hybridTopics (7)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 15%Citation Network 85%

Base Score Contribution

0.708

From this paper's citation signal

Citation Network Contribution

3.9

From 87 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment
ESMO Open20232 citations4 referencesContributes 0.275
Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
MedComm20236 citations9 referencesContributes 0.216
Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance
European Journal of Internal Medicine202314 citations13 referencesContributes 0.208
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer
JAMA Oncology202249 citations23 referencesContributes 0.170
Differential Survival Among Patients With Cancer by COVID-19 Vaccination Status: An Analysis of the ASCO COVID-19 Registry
JCO oncology advances.20245 citations11 referencesContributes 0.163

Authors (13)

Benjamin Bates ORCID,Yu Raymond Shao,Fang‐Chi Hsu ORCID,Feifan Liu ORCID,Vithal Madhira ORCID

Live enrichment

PubMed:35286152 PMC:PMC9061155

NIGMS NIH HHS

Grant: U54 GM104940

NIGMS NIH HHS

Grant: U54 GM104942

NIGMS NIH HHS

Grant: U54 GM115677

NCATS NIH HHS

Grant: UL1 TR001422

NCATS NIH HHS

Grant: UL1 TR001450

NCATS NIH HHS

Grant: UL1 TR001453

NCATS NIH HHS

Grant: UL1 TR001860

NCATS NIH HHS

Grant: UL1 TR001876

NCATS NIH HHS

Grant: UL1 TR002003

NCATS NIH HHS

Grant: UL1 TR002369

NCATS NIH HHS

Grant: UL1 TR002389

NCATS NIH HHS

Grant: UL1 TR002541

NCATS NIH HHS

Grant: UL1 TR002649

NCI NIH HHS

Grant: P30 CA177558

NIGMS NIH HHS

Grant: U54 GM115458

NCATS NIH HHS

Grant: UL1 TR001420

NCATS NIH HHS

Grant: UL1 TR001445

NCATS NIH HHS

Grant: UL1 TR001866

NCATS NIH HHS

Grant: UL1 TR001881

NCATS NIH HHS

Grant: UL1 TR002001

NCATS NIH HHS

Grant: UL1 TR002240

NCATS NIH HHS

Grant: UL1 TR002373

NCATS NIH HHS

Grant: UL1 TR002384

NCATS NIH HHS

Grant: UL1 TR003142

NIGMS NIH HHS

Grant: P20 GM121176

NCATS NIH HHS

Grant: UL1 TR001430

NCATS NIH HHS

Grant: UL1 TR001433

NCATS NIH HHS

Grant: UL1 TR001436

NCATS NIH HHS

Grant: UL1 TR002378

NCATS NIH HHS

Grant: UL1 TR002537

NCATS NIH HHS

Grant: UL1 TR002538

NCATS NIH HHS

Grant: UL1 TR003015

NCI NIH HHS

Grant: P30 CA082709

NCATS NIH HHS

Grant: UL1 TR001425

NCATS NIH HHS

Grant: UL1 TR001442

NCATS NIH HHS

Grant: UL1 TR001855

NCATS NIH HHS

Grant: UL1 TR001878

NCATS NIH HHS

Grant: UL1 TR002489

NCATS NIH HHS

Grant: UL1 TR002544

NCI NIH HHS

Grant: P30 CA012197

NIGMS NIH HHS

Grant: U54 GM104938

NIGMS NIH HHS

Grant: U54 GM104941

NCATS NIH HHS

Grant: UL1 TR001439

NCATS NIH HHS

Grant: UL1 TR001863

NCATS NIH HHS

Grant: UL1 TR001873

NCATS NIH HHS

Grant: UL1 TR002243

NCATS NIH HHS

Grant: UL1 TR002556

NCATS NIH HHS

Grant: UL1 TR004419

NCATS NIH HHS

Grant: UL1 TR002014

NCATS NIH HHS

Grant: UL1 TR002319

NCATS NIH HHS

Grant: UL1 TR002377

NCATS NIH HHS

Grant: UL1 TR002550

NCATS NIH HHS

Grant: UL1 TR002553

NCATS NIH HHS

Grant: UL1 TR003096

NCATS NIH HHS

Grant: UL1 TR003167

NIGMS NIH HHS

Grant: U54 GM115428

NIGMS NIH HHS

Grant: U54 GM115516

NCATS NIH HHS

Grant: UL1 TR001412

NCATS NIH HHS

Grant: UL1 TR002366

NCATS NIH HHS

Grant: UL1 TR002494

NCATS NIH HHS

Grant: UL1 TR002535

NCATS NIH HHS

Grant: UL1 TR003017

NCATS NIH HHS

Grant: UL1 TR003098

NCATS NIH HHS

Grant: U24 TR002306

NCATS NIH HHS

Grant: UL1 TR001414

NCATS NIH HHS

Grant: UL1 TR001449

NCATS NIH HHS

Grant: UL1 TR001872

NCATS NIH HHS

Grant: UL1 TR001998

NCATS NIH HHS

Grant: UL1 TR002345

NCATS NIH HHS

Grant: UL1 TR002529

NCATS NIH HHS

Grant: UL1 TR002645

NCATS NIH HHS

Grant: UL1 TR002733

NCATS NIH HHS

Grant: UL1 TR002736

NCATS NIH HHS

Grant: UL1 TR003107

hybridLicense: cc-by

publisherhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02419?role=tab

publisherhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02419

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/a03ec7ba-753d-4960-be4f-1200a21d4dbd/download

repositoryhttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1292&context=umccts_pubs

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9061155

MeSH Terms

HumansHematologic NeoplasmsCOVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineBreakthrough Infections

Related Papers (4)

Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts

Top 22%

0.902DataRank

Communications Medicine(2024)

co-cited

10.1038/s43856-024-00549-0

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

N/A

6.8DataRank · unranked

Nature Cancer(2021)

co-cited

10.1038/s43018-021-00274-w

The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative

Top 47%

0.382DataRank

American Journal of Transplantation(2024)

co-cited

10.1016/j.ajt.2024.06.001

Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C)

Top 28%

0.731DataRank

BMC Medical Research Methodology(2023)

co-cited

10.1186/s12874-023-01839-2